文献速递临床试验与 GCP流行病学与生物统计医学人工智能与信息学

支持父母与儿童共度封锁经验(SPARKLE):在COVID-19大流行期间嵌入正在进行的普通人群队列研究的数字育儿支持应用程序:随机对照试验研究方案的结构化摘要

Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2021-04-10

SPARKLE是一项嵌入英国Co-SPACE队列的两臂优越性平行组随机对照试验,旨在检验数字育儿支持应用程序Parent Positive能否逆转大流行对4-10岁儿童及父母的不利影响,并评估其成本效果。计划招募616名父母,按1:1随机分配至Parent Positive或常规随访组,主要结局为随机化后1个月父母报告的儿童品行问题(SDQ品行问题分量表)。

要点

  • SPARKLE嵌套于Co-SPACE队列,检验Parent Positive应用对儿童和父母结局的效果及成本效果。
  • 主要结局为随机化后1个月父母报告的儿童品行问题(SDQ品行问题分量表)。
  • 计划招募616名父母,1:1随机分配至Parent Positive或常规随访组。

核心结论

  • SPARKLE将检验Parent Positive数字育儿支持应用能否逆转COVID-19大流行对儿童和父母的不利影响,并评估其成本效果。

研究设计与样本

  • SPARKLE是一项两臂优越性平行组随机对照试验,嵌入英国全国性自选社区队列Co-SPACE。
  • 计划招募616名父母,按1:1简单随机化分配至Parent Positive组或常规随访组,每组308名。
  • 参与者为Co-SPACE中年龄≥18岁、有4-10岁儿童的父母。
  • 结局通过Qualtrics远程收集,时间点为基线(T1,随机化前Co-SPACE调查数据)、随机化后1个月(T2)和2个月(T3)。
  • 盲法:父母无法设盲,研究团队盲态成员和资深统计师不接触Qualtrics系统或数据, junior统计师全程非盲。

关键数值与推荐

  • 主要结局为随机化后1个月父母报告的儿童品行问题,采用Strengths and Difficulties Questionnaire品行问题分量表测量。
  • 将评估儿童和父母结局的组间差异、成本与服务利用、不良事件,并追踪Parent Positive使用情况。
  • 将检验儿童品行问题基线水平和Parent Positive使用情况是否调节效果,并探索其他基线特征或封锁情况的调节作用。

临床怎么用

  • 若有效,Parent Positive可作为可快速大规模交付的数字公共卫生干预,支持父母管理儿童行为、减少品行问题和家庭冲突。

局限性

  • 父母无法设盲,可能引入报告偏倚。
  • 样本来自Co-SPACE自选社区队列,可能限制推广性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The COVID-19 related lockdowns and distancing measures have presented families with unprecedented challenges. A UK-wide cohort study tracking changes in families' mental health since early lockdown (Co-SPACE) found a significant rise in primary school-aged children's behaviour problems and associated family-related stress. Three-quarters of parents in Co-SPACE also reported wanting extra support. In SPARKLE, we will examine whether providing Co-SPACE families with a smartphone application delivering information and parenting support, Parent Positive, can reverse the negative effects of the pandemic on children and parents. The efficacy on child and parent outcomes and cost-effectiveness of Parent Positive will be examined. We will also test whether the effects are moderated by pre-existing levels of child conduct problems and usage of Parent Positive. Exploratory analyses will examine whether other baseline characteristics or lockdown circumstances moderate the effects of Parent Positive. TRIAL DESIGN: SPARKLE is a two-arm superiority parallel group randomised controlled trial embedded in an existing large UK-wide self-selected community cohort - Co-SPACE. Those who consent to SPARKLE will be randomised 1:1 to either Parent Positive or Follow-up As Usual (FAU). PARTICIPANTS: Co-SPACE (a UK-wide longitudinal cohort study) parents aged ≥18 who have children aged 4-10 years will be eligible for SPARKLE. INTERVENTION AND COMPARATOR: Parent Positive: is a digital public health intervention that can be delivered rapidly at scale to support parents in managing their children's behaviour to reduce conduct problems and levels of family conflict, which were exacerbated during the first lockdown, and which may increase further in future months as families need to cope with continuous uncertainty and further disruption to their daily lives. Co-designed with parents and based on decades of parenting research, Parent Positive consists of three elements: (i) Parenting Boosters: where advice, delivered in the form of narrated animations, videos, graphics and text is provided to help parents with eight common parenting challenges; (ii) Parenting Exchange: a facilitated parent-to-parent communication and peer support platform and; (iii) Parent Resources: giving access to carefully selected high-quality, evidence-based online parenting resources. Follow-up as Usual: FAU was selected as a comparator because the public health nature meant that an active comparator was not appropriate due to the pragmatic, rapid implementation of the trial. Individuals randomised to FAU will receive no intervention for the first two months while the data for baseline (T1), T2 and T3 are collected. They will then be given full access to the app until 30th November 2021. MAIN OUTCOMES: Outcome measures will be collected remotely through Qualtrics according to the Co-SPACE schedule at baseline (T1), which will be the Co-SPACE survey data obtained immediately prior to randomisation, and then at one month (T2) and two months (T3) post-randomisation. Measures will be collected to assess group differences in child and parent outcomes, costs and service utilisation, and adverse events. Usage of Parent Positive will also be tracked. The primary outcome is parent-reported child conduct problems at one-month post-randomisation measured using the Strengths and Difficulties Questionnaire conduct problems subscale. RANDOMISATION: Enrolled participants will be allocated to Parent Positive or FAU at the ratio of 1:1 by simple randomisation using the Randomizer function within the Qualtrics programme. Neither blocking nor stratification will be used. BLINDING (MASKING): It is not possible to blind parents enrolled in the study and Qualtrics will automatically inform parents of their group allocation. Blinded members of the research team and the senior statistician will not be given access to the Qualtrics system or the data in order to remain blinded until after the analysis is complete. We do not anticipate any serious harms associated with taking part in the intervention, therefore there will be no need to unblind any blinded staff during the study. The junior statistician will be unblinded throughout. NUMBERS TO BE RANDOMISED (SAMPLE SIZE): A total of 616 will be recruited into the trial with 308 consenting parents randomised to each treatment arm. TRIAL STATUS: V1.0; 15.03.2021. Not yet recruiting. Anticipated start date: 1st April 2021. Anticipated end date for recruitment: 31st July 2021. TRIAL REGISTRATION: Clinicaltrial.gov: NCT04786080 . The trial was prospectively registered on 8 March 2021. FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file 2).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kostyrka-Allchorne K, Creswell C, Byford S, et al. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial. Trials. 2021. PMID: 33838678. doi:10.1186/s13063-021-05226-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。